Lorazepam
Product Images NDC 17478-040

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 17478-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lor06 0010 01

Chemical structure of lorazepam showing its fused benzodiazepine rings with chlorine substitutions on the phenyl groups and key functional groups including an amide and hydroxyl moiety.*

FDA Label Image

Lor06 0010 02

Label for Lorazepam Injection, USP, 2 mg/mL in a 1 mL sterile vial by Akorn. The label includes usage instructions for intramuscular or intravenous injection, storage directions to refrigerate and protect from light, and manufacturing information. Shows NDC 17478-040-01 and barcode.*

FDA Label Image

Lor06 0010 03

Lorazepam Injection, USP 2 mg/mL sterile vials carton from Akorn. The label indicates the product is for intramuscular or intravenous injection only and contains 10 sterile 1 mL vials. It includes active and inactive ingredient information and storage instructions to refrigerate and protect from light. The package also features a barcode and NDC 17478-040-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.